The University of Miami has won a $20 million grant from the National Institutes of Health to help translate research results into improved healthcare in areas including the use of stem cells to treat cardiovascular disease, testing women in Little Haiti for cervical cancer and preventing HIV transmission from mother to baby through antiretroviral injections.
The money will help UM establish the Miami Clinical and Translational Science Institute to ensure that scientific advancements go beyond medical journals and translate into improved care for patients, especially in marginalized communities that are often last to see the benefits of new products and procedures. The institute will have no physical center, but will support university research and clinical services offered by the UM health system.
“It takes 17 years for research to move from clinical study to providing care, and our mission is to help speed that process along,” said José Szapocznik, chairman of UM’s department of epidemiology and public health.
With this grant, UM joins a prestigious consortium across the nation that began with 12 academic health institutions in 2006 and now includes 60 institutions dedicated to bringing cutting-edge developments to the frontlines of healthcare.